PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 126-150 of 411

  • Linperlisib
    Cat. No.
    A20275

    Linperlisib (YY-20394)

    Synonyms: YY-20394

    Linperlisib is a potent and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM.

    1 mg
    $25.00
    2 mg
    $35.00
    All 8 sizes
  • NSC781406
    Cat. No.
    A20402

    NSC781406

    NSC781406 is a highly potent PI3K and mTOR inhibitor with an IC50 of 2 nM for PI3Kα.

    1 mg
    $20.00
    2 mg
    $30.00
    All 9 sizes
  • GDC-0326
    Cat. No.
    A20437

    GDC-0326

    GDC-0326 is a potent and selective PI3Kα inhibitor with a Ki of 0.2 nM.

    1 mg
    $25.00
    2 mg
    $40.00
    All 8 sizes
  • (Rac)-AZD 6482
    Cat. No.
    A20629

    (Rac)-AZD 6482

    Synonyms: (Rac)-KIN-193; KIN193; AZD6482

    Rac)-AZD 6482 ((Rac)-KIN-193) is a less active racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC50 of 0.69 nM.

    5 mg
    $290.00
    10 mg
    $535.00
    All 6 sizes
  • PI3K-IN-6
    Cat. No.
    A20687

    PI3K-IN-6

    PI3K-IN-6 (compound 20a) is an oral active and highly selective phosphoinositide 3-kinase (PI3K) β/δ inhibitor, with IC50 values of 7.8 nM/5.3 nM for PI3K β/δ, respectively.

    1 mg
    $200.00
    5 mg
    $500.00
    All 6 sizes
  • LAS191954
    Cat. No.
    A20691

    LAS191954

    LAS191954 is a potent, selective and orally active PI3Kδ inhibitor for inflammatory diseases treatment, with an IC50 of 2.6 nM.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • OSU-T315
    Cat. No.
    A20870

    OSU-T315

    OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain).

    1 mg
    $90.00
    2 mg
    $140.00
    All 9 sizes
  • CAL-130 Racemate
    Cat. No.
    A20942

    CAL-130 Racemate

    Synonyms: CAL130

    CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • YS-49
    Cat. No.
    A21198

    YS-49

    YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells.

    1 mg
    $35.00
    2 mg
    $50.00
    All 9 sizes
  • SAR405
    Cat. No.
    A21345

    SAR405

    SAR405 is a first-in-class, selective, and ATP-competitive PI3K class III (PI3KC3) isoform Vps34 inhibitor (IC50=1.2 nM; Kd=1.5 nM).

    1 mg
    $40.00
    2 mg
    $75.00
    All 7 sizes
  • Alpelisib hydrochloride
    Cat. No.
    A21794

    Alpelisib hydrochloride

    Synonyms: BYL-719 hydrochloride; BYL 719

    Alpelisib hydrochloride (BYL-719 hydrochloride) is a potent, orally active, and selective PI3Kα inhibitor with IC50s of 5 nM, 250 nM, 290 nM and 1200 nM for p110α, p110γ, p110δ, and p110β, respectively.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • Rigosertib sodium
    Cat. No.
    A21824

    Rigosertib sodium

    Synonyms: ON-01910 sodium; ON01910

    Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.

    5 mg
    $25.00
    10 mg
    $45.00
    All 7 sizes
  • Rigosertib
    Cat. No.
    A21868

    Rigosertib

    Synonyms: ON-01910

    Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.

    2 mg
    $25.00
    5 mg
    $50.00
    All 5 sizes
  • Umbralisib R-enantiomer
    Cat. No.
    A21993

    Umbralisib R-enantiomer

    Synonyms: TGR-1202 R-enantiomer; TGR1202; RP5264 R-enantiomer; RP 5264

    Umbralisib R-enantiomer (TGR-1202 R-enantiomer) is a PI3Kδ inhibitor, which is the less active enantiomer of TGR-1202.

    1 mg
    $190.00
    2 mg
    $370.00
    All 8 sizes
  • GNE-490
    Cat. No.
    A22231

    GNE-490

    GNE-490 is a highly selective pan-PI3K inhibitor that demonstrates selectivity over mTOR.

    1 mg
    $70.00
    2 mg
    $110.00
    All 9 sizes
  • Gallein
    Cat. No.
    A22304

    Gallein

    Synonyms: Pyrogallol phthalein

    Gallein is a G protein βγ (Gβγ) subunit signalling inhibitor. Gallein disrupts the interaction of Gβγ subunits with the PI3Kγ. Anticancer agent.

    5 mg
    $25.00
    10 mg
    $35.00
    All 6 sizes
  • SRX3207
    Cat. No.
    A22305

    SRX3207

    SRX3207 is an orally active and first-in-class dual Syk/PI3K inhibitor, with IC50 values of 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 relieves tumor immunosuppression.

    1 mg
    $45.00
    5 mg
    $125.00
    All 7 sizes
  • Nemiralisib
    Cat. No.
    A22373

    Nemiralisib

    Synonyms: GSK2269557 (free base)

    Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3Kδ inhibitor with a pKi of 9.9.

    1 mg
    $35.00
    2 mg
    $50.00
    All 8 sizes
  • PI3Kδ-IN-5
    Cat. No.
    A22381

    PI3Kδ-IN-5 (Compound 7n)

    Synonyms: Compound 7n

    Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM].

    1 mg
    $45.00
    2 mg
    $85.00
    All 8 sizes
  • Sophocarpine monohydrate
    Cat. No.
    A22386

    Sophocarpine monohydrate

    Sophocarpine (monohydrate) is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory.

    5 mg
    $20.00
    10 mg
    $30.00
    All 5 sizes
  • Erucic acid
    Cat. No.
    A22389

    Erucic acid

    Erucic acid, a monounsaturated fatty acid (MUFA), is isolated from the seed of Raphanus sativus L. Erucic acid can readily cross the blood-brain barrier (BBB), it has been reported to normalize the accumulation of very long-chain fatty acids in the brain. Erucic acid can improve cognitive impairment and be effective against dementia .

    100 mg
    $40.00
    500 mg
    $130.00
    All 3 sizes
  • AZD6482 (S-isomer)
    Cat. No.
    A22606

    AZD6482 (S-isomer)

    AZD6482 (S-isomer), CAS#1173900-37-2, is an isomer of AZD6482 (MedKoo Cat#406268) with S-configuration. AZD6482 is a potent, selective and ATP competitive PI3Kβ inhibitor (IC(50) 0.01 μm).

    25 mg
    $1,665.00
    50 mg
    $2,175.00
    All 3 sizes
  • MDK34597
    Cat. No.
    A22652

    MDK34597

    MDK34597 is a PI3K inhibitor. MDK34597 has CAS#371934-59-7, the last 5 digits of which were used for its name. MDK34597 is an analog of PI-103 and acts as a dual PI3K/mTOR Inhibitor.

    1 mg
    $50.00
    5 mg
    $130.00
    All 6 sizes

Items 126-150 of 411

Added to your cart

View Cart Checkout

    Loading...